Trial Profile
Effect of eribulin in patients with metastatic breast cancer on circulating TGFβ and TNFα: The TRANSERI project
Status:
Recruiting
Phase of Trial:
Phase IV
Latest Information Update: 21 Jun 2018
Price :
$35
*
At a glance
- Drugs Eribulin (Primary)
- Indications Advanced breast cancer
- Focus Pharmacodynamics; Therapeutic Use
- Acronyms The TRANSERI project; TRANSERI
- 05 Jun 2018 Results (n=24) investigating the interference among E and TGF-beta and TNF-alfa levels in pts and the correlation with the outcome and the metastatic spread presented at the 54th Annual Meeting of the American Society of Clinical Oncology
- 16 Jan 2018 New trial record
- 09 Dec 2017 Results presented at the 40th Annual San Antonio Breast Cancer Symposium